Interventional psychiatry is advancing rapidly, but commercializing new treatments in this space requires navigating scientific complexity, clinical-workflow integration, regulatory ambiguity and evolving payer expectations. This workshop brings together leaders across drug development, clinical services, digital therapeutics and health-system innovation to unpack what it takes to bring interventional psychiatric treatments to market effectively and responsibly. Through real-world case studies and cross-sector perspectives, attendees will explore how to position novel modalities, build scalable delivery models, integrate biomarkers and patient-selection tools, evaluate reimbursement pathways, and ensure safe, consistent implementation across diverse clinical environments.

• Define the commercial, clinical and operational considerations required to bring interventional psychiatric treatments to market, including positioning, differentiation and workflow integration
• Examine the infrastructure, training, safety and scalability requirements needed for real-world delivery across clinics, health systems and community-based care settings
• Identify viable reimbursement and market-access pathways by understanding payer priorities, value demonstration, and the evidence needed to support sustainable adoption